Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS
Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive Ultherapy® skin lifting technology. This advanced version of Ultherapy® promises…
Viruses Neutralized by Electromagnetic Waves: e4life at Arab Health Dubai
Viruses Neutralized by Electromagnetic Waves: e4life at Arab Health Dubai e4life will play a key role at the landmark 50th edition of Arab Health, the premier health trade fair in the Middle East. The Italian company will showcase its cutting-edge…
Innovation by USound Enables Advanced Health Monitoring in TWS Earphones
Innovation by USound Enables Advanced Health Monitoring in TWS Earphones USound, a global leader in Micro Electronic Mechanical Systems (MEMS) speakers, has unveiled a groundbreaking innovation that will enable true wireless systems (TWS) earphones to feature advanced health monitoring capabilities…
Diabetes Breakthrough: IPA Pioneers AI-Designed GLP-1 Therapies
Diabetes Breakthrough: IPA Pioneers AI-Designed GLP-1 Therapies ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) has pioneered a new class of GLP-1 therapies developed entirely through artificial intelligence, aiming to enhance the efficacy, safety, longevity, and patient satisfaction in diabetes treatment. These…
Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA
Vaccines Development: Vaxxas and CEPI Advance $4.8M Program for Needle-Free mRNA Vaxxas, a clinical-stage biotechnology company focused on commercializing its innovative high-density microarray patch (HD-MAP) vaccination platform, today announced that the Coalition for Epidemic Preparedness Innovations (CEPI) has approved the…
Collaboration Announced Between Simulations Plus and ETC for GastroPlus®
Collaboration Announced Between Simulations Plus and ETC for GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), a leader in biosimulation and performance solutions for the biopharma industry, has entered into an exciting new collaboration with the Enabling Technologies Consortium (ETC). This funded…
Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment
Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment BPGbio, Inc., a clinical-stage biopharma company specializing in mitochondrial biology and protein homeostasis, today revealed new findings in pancreatic cancer subtyping from its long-term Project Survival® (NCT2781012)…
DNA Nanobots Appoints Dr. John C. Byrd to Scientific Advisory Board
DNA Nanobots Appoints Dr. John C. Byrd to Scientific Advisory Board DNA Nanobots, a leader in biotechnology specializing in DNA nanoparticles for targeted therapeutics, has announced the addition of Dr. John C. Byrd, M.D., to its Scientific Advisory Board (SAB).…
Partners at Red Cell Welcome Timothy G. Ferris, MD, to Lead Healthcare Practice
Partners at Red Cell Welcome Timothy G. Ferris, MD, to Lead Healthcare Practice Red Cell Partners, a firm dedicated to incubating and investing in technology-driven companies that are revolutionizing healthcare, cyber, and national security, has announced that Dr. Timothy G.…
VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers
VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers VSee Health, Inc. (Nasdaq: VSEE), a leading provider of comprehensive digital health services and tailored telehealth workflows, has secured contracts totaling approximately $935,000 with several prominent medical technology solution companies.…
Award-Winning PICO Nexμs to be Showcased by Nordson EFD at MD&M West 2025
Award-Winning PICO Nexμs to be Showcased by Nordson EFD at MD&M West 2025 Nordson EFD, a division of Nordson Corporation (NASDAQ: NDSN), will highlight its award-winning PICO Nexμs jetting system at MD&M West, scheduled to take place at the Anaheim…
Charles River Expands Apollo™ Ecosystem with Custom Client Experiences
Charles River Expands Apollo™ Ecosystem with Custom Client Experiences Charles River Laboratories International, Inc. (NYSE: CRL) today introduced Apollo™ for CRADL®, a secure cloud-based platform designed to enhance its vivarium rental services. This digital platform connects clients effortlessly with the…